12-04-2017 All Resources Directed towards Replicon Health Ltd.
All available resources and expertise of Replicon Corporate Finance are currently in use of the sister company Replicon Health Ltd. This positive “overflow” situation seems to continue until year 2023.
We wish our customers best luck and success in their business endeavours!
Petteri Hirvonen, CEO
Replicon Group
petteri.hirvonen [at] replicon.fi
Ajakohtaista (embedded) UK
-
12-04-2017 All Resources in Replicon Health Ltd.
-
31-03-2016 Innovative Expansion and Financing Strategy
-
04-08-2015 Service Offering: “Acid tests” for Life Science Sector Investment Strategies and Investments
-
03-03-2015 Growth Based on Innovative and Appealing Products
-
01-04-2014 Replicon Gains Accreditation for Two Useful Client Programs
-
07-10-2013 Replicon Evaluates Production Methods for Unique Food Supplement
-
06-03-2013 Replicon Initiates Industrial Licensing Project
-
01-03-2013 Learning Points from Nalmefene / Selincro
-
25-10-2012 Comparing Economics of Wind Power Alternatives
-
13-08-2012 OS/G Advertising and Marketing Agengy Ezpa Merge
-
09-05-2012 Current Investment Opportunities for Investors and Financiers
-
20-02-2012 - Replicon Compiles Business Strategy and Financing Plan for 6 M€ Wellness Concept
-
31-08-2011 - Replicon Valuation Analyses Enhances M&A